Managing Process Complexity in the Pharmaceutical Industry with PLM (Strategy Focus)

Table of Contents

• DATAMONITOR VIEW
  • CATALYST
  • SUMMARY
• ANALYSIS
  • Pharmaceutical product lifecycle management technology is gaining momentum
    • A variety of challenges is fueling PLM adoption in the pharmaceutical industry
    • Cultural and technological barriers have inhibited wider adoption of PLM in the pharmaceutical market
    • PLM in the pharmaceutical industry is poised for strong growth and vendors have an important role to play
  • PLM in the life sciences should map to business processes, managing process complexity
    • Pharmaceutical companies produce what they discover, not what they invent
    • The pharmaceutical sector looks for PLM that can manage process complexity
  • PLM is successful when handled as an enterprise, strategic initiative
    • As part of a company' s product development business strategy, PLM is discussed among executives
    • Collaboration, through enterprise PLM, breaks down individual silos
    • Reducing drug development costs is a major strategic goal for implementing enterprise PLM
    • The benefits of an enterprise-wide PLM solution do come with risks
    • A phased implementation approach is most likely for pharmaceutical organizations
  • Partnering with a technology vendor may be a necessary PLM strategy
    • A long-term commitment to the project indicates a willingness to share risk
    • Innovative and flexible vendors will attract most business
    • Implementation efficiency is an important vendor characteristic
    • Track record of success reflects on a vendor' s reliability and trustworthiness
• ACTIONS
  • PLM must support executive-level decisions
  • Have a long-term vision but establish short-term milestones
  • Look beyond point solutions for a strategic approach to PLM
• APPENDIX
• APPENDIX
  • Definitions
  • Abbreviations
  • Methodology
  • Further reading
  • Ask the analyst
  • Datamonitor consulting
  • Disclaimer
  • List of Figures
    • Figure 1: In the pharmaceutical industry, complexity in the process defines the product
    • Figure 2: Making a value proposition for PLM as a strategy in the pharmaceutical product lifecycle
    • Figure 3: As the Big Pharma begins to face its information management needs, enterprise PLM investments will grow
    • Figure 4: Examples of "must-have" and "nice-to-have" criteria pharmaceutical companies use for selecting a PLM vendor as potential partner